V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003705 | 10002343 | 1.75 | 89 | Neo-adjuvant (N) | 2017-06-02 | 2017-06-03 | Capecitabine 35days + RT | N | Y | 10486785 | CAPECITABINE + RT |
| 10003706 | 10006487 | 1.67 | 65.6 | Adjuvant (A) | 2018-08-04 | 2019-01-05 | FEC + DOCETAXEL | 2 | Y | 10486800 | FEC + DOCETAXEL |
| 10003707 | 10002344 | 1.8 | null | Curative (C) | 2017-01-18 | 2017-01-18 | FEC + DOCETAXEL | 2 | N | 10486813 | FEC + DOCETAXEL |
| 10003708 | 10002345 | 1.65 | 82.6 | Adjuvant (A) | 2015-01-02 | 2015-01-05 | Azacitidine | N | N | 10486849 | CTD |
| 10003709 | 10002346 | null | null | Disease modification (D) | 2015-11-01 | 2015-11-29 | Chlorambucil | N | N | 10486870 | CTD |
| 10003710 | 10002346 | 1.62 | 82 | Neo-adjuvant (N) | 2014-08-05 | 2014-08-26 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 10486870 | FLUOROURACIL |
| 10003711 | 10002346 | 1.8 | 79.5 | Palliative (P) | null | 2014-06-24 | Chlorambucil | N | N | 10486870 | CVD |
| 10003712 | 10002346 | 1.63 | 64 | Neo-adjuvant (N) | 2018-08-07 | 2018-08-18 | Gemcitabine + Capecitabine | 02 | Y | 10486870 | BORTEZOMIB |
| 10003713 | 10002347 | 1.71 | 90.1 | Disease modification (D) | 2017-11-14 | 2017-11-14 | EC | 02 | N | 10486988 | FLUOROURACIL + MITOMYCIN + RT |
| 10003714 | 10002347 | 1.7 | 68.7 | Neo-adjuvant (N) | 2016-11-07 | 2016-11-09 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10486988 | CTD |
| 10003715 | 10002348 | null | 90.6 | Curative (C) | 2018-03-27 | 2018-04-15 | CAPECITABINE + RT | 2 | Y | 10487051 | CAPECITABINE + RT |
| 10003716 | 10002348 | 1.69 | 91.05 | Palliative (P) | null | 2017-03-20 | Abiraterone | N | N | 10487051 | CISPLATIN + ETOPOSIDE |
| 10003717 | 10002348 | 1.77 | 72 | Palliative (P) | 2016-01-30 | 2016-02-14 | CISPLATIN + RT | N | Y | 10487051 | CISPLATIN + RT |
| 10003718 | 10002349 | null | 69.3 | Curative (C) | null | 2015-12-17 | Capecitabine 35days + RT | N | Y | 10487142 | CAPECITABINE + RT |
| 10003719 | 10006491 | 1.73 | 55.6 | Neo-adjuvant (N) | null | 2015-09-06 | FEC + DOCETAXEL | N | N | 10487162 | FEC + DOCETAXEL |
| 10003720 | 10006491 | null | 80 | Curative (C) | 2018-11-27 | 2018-11-28 | Paclitaxel 7 day | N | N | 10487162 | CAPECITABINE + CISPLATIN |
| 10003721 | 10008815 | 1.62 | 62 | Adjuvant (A) | 2017-07-01 | 2017-07-01 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10487248 | FLUOROURACIL + MITOMYCIN + RT |
| 10003722 | 10002350 | 0 | 66.6 | Palliative (P) | 2015-07-05 | 2015-07-21 | Irinotecan + Modified De Gramont | 2 | Y | 10487275 | IRINOTECAN + MDG |
| 10003723 | 10002351 | 1.75 | 74.4 | Neo-adjuvant (N) | 2016-08-13 | 2016-08-13 | Abiraterone | 02 | Y | 10487339 | CAPECITABINE + GEMCITABINE |
| 10003724 | 10002351 | 1.72 | 71.2 | null | 2019-04-03 | 2019-04-06 | Capecitabine 42days + RT | N | Y | 10487339 | CAPECITABINE + RT |
| 10003725 | 10002351 | 1.6 | 56.8 | Curative (C) | 2015-01-16 | 2015-01-16 | Chlorambucil | N | N | 10487339 | BORTEZOMIB |
| 10003726 | 10002352 | 1.7 | 75.9 | Curative (C) | 2017-03-23 | 2017-03-26 | CAPECITABINE + RT | 02 | N | 10487433 | CAPECITABINE + RT |
| 10003727 | 10002352 | 1.6 | 91.5 | Palliative (P) | 2016-09-05 | 2016-09-11 | Fluorouricil + Folonic Acid (MdG) | null | N | 10487433 | FLUOROURACIL |
| 10003728 | 10002353 | null | 81.6 | Adjuvant (A) | 2016-07-16 | 2016-07-16 | Temozolomide + RT | N | N | 10487503 | TEMOZOLOMIDE + RT |
| 10003729 | 10002354 | null | 74 | Curative (C) | 2018-07-10 | 2018-07-10 | Gemcitabine + Capecitabine | N | N | 10487540 | CISPLATIN + ETOPOSIDE |
| 10003730 | 10002355 | 1.75 | 68 | Palliative (P) | 2016-07-30 | 2016-08-28 | Capecitabine + Cisplatin | N | N | 10487550 | BCG |
| 10003731 | 10002356 | 0 | 93 | Curative (C) | 2016-05-13 | 2016-06-26 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 10487560 | PACLITAXEL |
| 10003732 | 10006494 | 1.85 | 74 | Adjuvant (A) | 2018-06-07 | 2018-06-07 | FLUOROURACIL + IRINOTECAN | 02 | Y | 10487569 | IRINOTECAN + MDG |
| 10003733 | 10002357 | 1.57 | 61.4 | Adjuvant (A) | 2017-09-24 | 2017-10-16 | FEC + DOCETAXEL | N | N | 10487591 | FEC + DOCETAXEL |
| 10003734 | 10002357 | 1.8 | 96.2 | null | 2017-12-05 | 2017-12-05 | Gemcitabine + Capecitabine | 2 | N | 10487591 | ABIRATERONE |
| 10003735 | 10002357 | 1.57 | 66 | Curative (C) | 2017-08-05 | 2017-08-12 | Paclitaxel 7 day | 02 | N | 10487591 | EC |
| 10003736 | 10002358 | 1.55 | 48.2 | Neo-adjuvant (N) | 2017-03-14 | 2017-03-18 | CHOP - 21 days | 02 | null | 10487624 | BORTEZOMIB |
| 10003737 | 10002359 | 1.82 | 68.9 | Palliative (P) | 2016-06-29 | 2016-06-29 | Irinotecan + Modified De Gramont | 2 | N | 10487632 | IRINOTECAN + MDG |
| 10003738 | 10002360 | 1.53 | 77.9 | Palliative (P) | 2018-01-15 | 2018-01-15 | Gemcitabine + Capecitabine | N | N | 10487678 | EC |
| 10003739 | 10002360 | 0 | 65.2 | Disease modification (D) | 2014-11-19 | 2014-11-19 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | 10487678 | IMATINIB |
| 10003740 | 10002361 | 1.74 | 68.9 | Disease modification (D) | 2017-09-11 | 2017-09-15 | CHOP | N | Y | 10487753 | BORTEZOMIB |
| 10003741 | 10006497 | 1.6 | 65 | null | 2016-07-30 | 2016-08-23 | Irinotecan + Modified De Gramont | N | N | 10487857 | IRINOTECAN + MDG |
| 10003742 | 10002362 | 1.6 | 82 | Palliative (P) | 2018-09-27 | 2018-10-12 | Irinotecan + Modified De Gramont | N | Y | 10487870 | IRINOTECAN + MDG |
| 10003743 | 10002363 | 1.6 | 0 | null | 2017-01-08 | 2017-01-09 | Capecitabine + Cisplatin | N | N | 10487874 | CISPLATIN + ETOPOSIDE |
| 10003744 | 10002364 | 1.72 | 63.8 | Palliative (P) | 2017-09-20 | 2017-09-27 | Capecitabine + Cisplatin | 2 | N | 10487919 | CVD |
| 10003745 | 10006498 | null | 45.95 | Curative (C) | 2018-06-03 | 2018-06-26 | CISPLATIN + ETOPOSIDE | 02 | Y | 10487927 | CHOP |
| 10003746 | 10006498 | 1.71 | 99.5 | Neo-adjuvant (N) | null | 2015-10-30 | FLUOROURACIL | N | N | 10487927 | FLUOROURACIL |
| 10003747 | 10006498 | 1.66 | 73.4 | Palliative (P) | 2017-12-17 | 2017-12-18 | Bortezomib + Cyclophos + Dex | N | N | 10487927 | CVD |
| 10003748 | 10002365 | 1.78 | null | Palliative (P) | 2018-08-15 | 2018-09-10 | CHOP - 14 days | N | Y | 10487962 | ABIRATERONE |
| 10003749 | 10002366 | 1.6 | 64.1 | Curative (C) | 2018-04-13 | 2018-04-14 | BCG Intravesical | 02 | N | 10487988 | IMATINIB |
| 10003750 | 10002367 | 0 | 82 | Curative (C) | 2015-10-05 | 2015-10-07 | ABVD | 2 | N | 10488007 | CTD |
| 10003751 | 10002368 | 1.7 | 75.9 | Adjuvant (A) | 2015-07-20 | 2015-08-07 | Chlorambucil | N | N | 10488040 | ABIRATERONE |
| 10003752 | 10002369 | 1.72 | 91.5 | Palliative (P) | 2016-12-02 | 2016-12-16 | Azacitidine | 02 | N | 10488066 | CHLORAMBUCIL |
| 10003753 | 10002370 | 1.73 | 82 | Disease modification (D) | 2016-10-28 | 2016-11-07 | Temozolomide + RT | 02 | null | 10488070 | ABIRATERONE |
| 10003754 | 10002371 | null | 78 | Curative (C) | 2016-04-01 | 2016-04-03 | Chlorambucil | N | N | 10488106 | CTD |